Magico Health

Magico BioSolutions is a biotechnology startup developing a next-generation plant-derived therapeutic platform designed to support the treatment of aggressive cancers, with an initial focus on pancreatic cancer—one of the deadliest malignancies worldwide, with a five-year survival rate below 12%. Despite advances in chemotherapy, treatment resistance, toxicity, and limited efficacy remain critical challenges. Patients urgently need safer adjunct solutions that enhance therapeutic response without adding additional burden to the body.

Our innovation combines two scientifically studied bioactive compounds—curcumin and apigenin—engineered into a stabilized formulation to improve bioavailability and synergistic activity. Both molecules have demonstrated multi-target anticancer properties in peer-reviewed research, including modulation of the PI3K/Akt and NF-κB pathways, induction of apoptosis, reduction of angiogenesis, and enhancement of oxidative stress selectively in tumor cells. By